[go: up one dir, main page]

JP2014048074A - Artificial stool composition having good addition recovery ratio - Google Patents

Artificial stool composition having good addition recovery ratio Download PDF

Info

Publication number
JP2014048074A
JP2014048074A JP2012189325A JP2012189325A JP2014048074A JP 2014048074 A JP2014048074 A JP 2014048074A JP 2012189325 A JP2012189325 A JP 2012189325A JP 2012189325 A JP2012189325 A JP 2012189325A JP 2014048074 A JP2014048074 A JP 2014048074A
Authority
JP
Japan
Prior art keywords
stool
hemoglobin
transferrin
collagen
gelatin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012189325A
Other languages
Japanese (ja)
Inventor
Akira Miike
彰 三池
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2012189325A priority Critical patent/JP2014048074A/en
Publication of JP2014048074A publication Critical patent/JP2014048074A/en
Pending legal-status Critical Current

Links

Images

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide an artificial stool composition which allows hemoglobin or transferrin to be measured to fully diffuse and dissolve into a stool dilution from a matrix without being trapped.SOLUTION: By adding gelatin, collagen, degradation products thereof, or the like to an artificial stool as an absorption inhibitor for powder, such as rice powder, used as a base material of an artificial stool, added hemoglobin or transferrin can be fully eluted into a dilution, which leads to more accurate measurements.

Description

本発明は大腸癌検診分野において、サーベイなどに使用される人工的な擬似便の組成、及びその製造方法に関する。   The present invention relates to a composition of artificial artificial stool used for surveys and the like in the field of colorectal cancer screening, and a method for producing the same.

便中ヘモグロビンや便中トランスフェリンは、大腸癌の健診に重要なスクリーニング検査になっている。しかし、この重要な健診項目については、まだ標準化が行われておらず、各施設の測定値がどうなっているのかがほとんど不明で、その状況を知るために行われる全国的な検査値のサーベイランス(以後サーベイという)も実質上行われていないのが現状である。この理由は実便検体中のヘモグロビンやトランスフェリンの安定性が極端に悪く、サーベイ用に実便検体を配布・保存する事が実質不可能である事が1つの要因であった。そのため、安定性については、便の実検体を使用する代わりに、米粉や小麦粉、ジャガイモデンプン、トウモロコシ粉、大豆蛋白等の粉体を主成分にし、ヘモグロビンまたはトランスフェリン及びその安定化剤を含む溶液を添加して人工的な擬似便を作成し、配布・保存に安定な擬似便を使用する事で、解決に供しようとする技術が出願されている。
しかし、擬似便でヘモグロビンまたはトランスフェリンを安定化させても、それだけでは標準化が可能になるわけではない。実際のヘモグロビンまたはトランスフェリンを測定する試薬や便を採取する採便器も標準化に大きなファクターである。図1は現在使用されている便を採取する採便器の使用方法を示している。採取された疑似便は希釈液が封入された希釈容器に入り、ここで分散され、ヘモグロビンまたはトランスフェリンは疑似便の中から出て溶解する。
具体的には、採便器で採取し、それを採便器に付随した希釈液が内封された希釈容器に挿入して擬似便を分散・溶解・希釈して、測定項目であるヘモグロビンまたはトランスフェリンを測定する訳であるが、従来の擬似便ではヘモグロビンまたはトランスフェリンの一部が不溶性の擬似便素材の粉のマトリックス中に補足されて100%希釈液に回収されず、正確にヘモグロビンまたはトランスフェリンが測定できている訳ではなかった。さらに、測定試薬製造各社の採便器はそれぞれ異なっており、また希釈液もそれぞれに異なっているため、マトリックス中に補足されるヘモグロビンまたはトランスフェリン量もそれぞれに異なっていた。即ち、測定されるべきヘモグロビンまたはトランスフェリンがマトリックス補足により減少し、100%正確に測定する事が出来なかった。これでは擬似便中のヘモグロビンまたはトランスフェリンを一定量含有させ、測定値をその量に統一させるべく行われるサーベイがこの様な擬似便では不完全なものになり、重要な大腸癌検診項目である便中ヘモグロビンまたはトランスフェリン測定の標準化を妨げていた。
Fecal hemoglobin and fecal transferrin are important screening tests for colorectal cancer. However, this important medical examination item has not been standardized yet, and it is almost unknown what the measurement value of each facility is. Surveillance (hereinafter referred to as “survey”) is not actually conducted. One reason for this was that the stability of hemoglobin and transferrin in actual stool samples was extremely poor, and it was virtually impossible to distribute and store actual stool samples for surveys. Therefore, for stability, instead of using a fecal sample, a solution containing rice flour, wheat flour, potato starch, corn flour, soy protein, etc. as the main component, hemoglobin or transferrin and its stabilizer is used. An application has been filed for a technique to solve the problem by adding artificial stool and using stable stool for distribution and storage.
However, stabilization of hemoglobin or transferrin with artificial stool does not enable standardization by itself. A reagent for measuring actual hemoglobin or transferrin and a stool collection device for collecting stool are also a major factor in standardization. FIG. 1 shows a method of using a stool collector that collects stool currently in use. The collected stool enters a dilution container in which a diluent is enclosed, and is dispersed therein, and hemoglobin or transferrin is dissolved out of the stool.
Specifically, it is collected with a stool collection instrument, inserted into a dilution container containing a diluent attached to the stool collection instrument, and pseudo stool is dispersed, dissolved, and diluted, and hemoglobin or transferrin as a measurement item is added. In the case of conventional stool, a part of hemoglobin or transferrin is captured in the matrix of insoluble stool material powder and is not recovered in a 100% diluted solution, so that hemoglobin or transferrin can be measured accurately. I didn't mean. Furthermore, since the stool collection apparatus of each measuring reagent manufacturer was different, and the dilutions were also different, the amounts of hemoglobin or transferrin supplemented in the matrix were also different. That is, hemoglobin or transferrin to be measured was reduced by matrix supplementation, and 100% could not be measured accurately. In this case, the survey conducted to contain a certain amount of hemoglobin or transferrin in simulated stool and to unify the measured values to that amount is incomplete in such simulated stool, which is an important colorectal cancer screening item stool It interfered with the standardization of medium hemoglobin or transferrin measurements.

従来、ヘモグロビンまたはトランスフェリンがその不安定性のために、安定性を向上させる試みは多くなされてきたが、本発明のように、添加したヘモグロビンまたはトランスフェリンを粉のマトリックス中に補足されない様にし、希釈液中に100%溶出させて測定する試薬系に取り入れる様な試み、即ち添加回収率を100%にする試みは行われた事が無い。具体的には粉体マトリックスにヘモグロビンまたはトランスフェリンを添加し、それを希釈溶液中にすべて分散溶解させて回収するという面から擬似便組成、または希釈液を検討したことが無く、そのような作用を持つ物の例は知られていない。
この様な状況では、採便器の異なる全社を含めたサーベイデータのまとまりは望めない状況であった。
Conventionally, many attempts have been made to improve the stability of hemoglobin or transferrin due to its instability. No attempt has been made to incorporate 100% into the reagent system to be measured, that is, to make the addition recovery rate 100%. Specifically, we have not studied pseudo stool composition or diluting solution from the aspect of adding hemoglobin or transferrin to the powder matrix and dispersing and dissolving it all in the diluting solution. There are no known examples of what you have.
In such a situation, it was impossible to collect survey data including the entire company with different toilet collection devices.

特開平11−242027号Japanese Patent Laid-Open No. 11-242027 特開2003−185654号JP 2003-185654 A 特願2012−185962号Japanese Patent Application No. 2012-185962

Therapeutic Res.vol.15 suppl.2 18−23;1994Therapeutic Res. vol. 15 suppl. 2 18-23; 1994

擬似便のマトリックスからヘモグロビンまたはトランスフェリンが100%希釈液中に分散溶解する擬似便組成が求められていた。 There has been a demand for a pseudo stool composition in which hemoglobin or transferrin is dispersed and dissolved in a 100% diluent from a pseudo stool matrix.

発明者は種々検討の結果、意外にも吸着阻止剤としてエンザイムイムノアッセイなどで良く使用される牛血清アルブミンでは、むしろ逆に擬似便素材にヘモグロビンまたはトランスフェリンを吸着させてマトリックス中に留め、回収率を悪くする作用を有していることが判明した一方、意外にもゼラチンやコラーゲン、あるいはその分解物などが回収率を100%希釈液中溶出させる作用を保つことが判り、本発明を完成した。 As a result of various studies, the inventor unexpectedly used bovine serum albumin, which is often used in enzyme immunoassays as an adsorption inhibitor, rather, adsorbs hemoglobin or transferrin on a pseudo-stool material and retains it in the matrix to increase the recovery rate. While it has been found that it has a detrimental effect, it was surprisingly found that gelatin, collagen, or a degradation product thereof maintained the effect of eluting the recovery rate in a 100% diluted solution, thus completing the present invention.

ゼラチンの溶液は、温度によってゲル状になったり流動性のあるゾル状になったりする事で知られており、通常これをエンザイムイムノアッセイの吸着防止に使用することはその取り扱いの難しさから行われてこなかった。また、エンザイムイムノアッセイの場合の吸着相手はスチレンなどのプラスチック類であるが、疑似便の場合は米粉などセルロースが主体の天然物であり、エンザイムイムノアッセイの場合の技術的な知見は利用できないし、検討が行われた事もない。 Gelatin solutions are known to form gels or flowable sols depending on the temperature, and are usually used to prevent adsorption in enzyme immunoassays because of their difficulty in handling. I did not come. In addition, the adsorption partner in the case of enzyme immunoassay is a plastic such as styrene, but in the case of artificial stool, it is a natural product mainly composed of cellulose such as rice flour. Has never been done.

発明者は、本目的のために、吸着防止効果の指標として以下の方法で回収率を算出する方法を考えた。即ち、試験管に擬似便素材である粉体の一定量(1gとする)に、回収率を求めたい添加物と共に既知量のヘモグロビンまたはトランスフェリンを含有した溶液(ヘモグロビンまたはトランスフェリン濃度をAとする)を適量(BmLとする)添加して擬似便様のペーストをいったん作成する。1時間放置後、試験管に精製水を一定量(2mLとする)追加添加してヘモグロビンまたはトランスフェリンを溶液中に溶出させ、遠心分離後に上清のヘモグロビンまたはトランスフェリンを測定(濃度をCとする)して回収率を算出する方法である。なお、擬似便素材の粉体自身が溶液中の一部水分のみを吸着・結合してしまい、これが再溶出出来ない固定化水分となる事も考えなければならない。この固定化水分量(Dとする)はヘモグロビンまたはトランスフェリンを溶解している液から除外されるため、計算は次の式にて概算計算される。

Figure 2014048074
For this purpose, the inventor considered a method of calculating the recovery rate by the following method as an index of the adsorption prevention effect. That is, a solution containing a known amount of hemoglobin or transferrin together with an additive for which a recovery rate is to be obtained (a hemoglobin or transferrin concentration is A) in a fixed amount (1 g) of powder that is pseudo fecal material in a test tube A suitable amount (BmL) is added to make a pseudo-stool-like paste. After standing for 1 hour, add a fixed amount (2 mL) of purified water to the test tube to elute hemoglobin or transferrin in the solution, and measure the hemoglobin or transferrin in the supernatant after centrifugation (concentration is C). Then, the recovery rate is calculated. In addition, it must be considered that the powder of the artificial stool material itself adsorbs and binds only a part of moisture in the solution, which becomes fixed moisture that cannot be re-eluted. Since this immobilized water content (referred to as D) is excluded from the solution in which hemoglobin or transferrin is dissolved, the calculation is roughly calculated by the following equation.
Figure 2014048074

本発明および発明者が先に出願した特許(特願2012―185962)の方法によって作成される一定量のヘモグロビンまたはトランスフェリンを添加した擬似便を使用してサーベイを行ったり、精度管理を行う事により、市販の便ヘモグロビンまたはトランスフェリン測定用の採便器、測定試薬の標準化が可能になる。 By conducting surveys or performing quality control using simulated stool supplemented with a certain amount of hemoglobin or transferrin prepared by the method of the present invention and the patent previously filed by the inventor (Japanese Patent Application No. 2012-185962) This makes it possible to standardize commercially available stool hemoglobin or transferrin measuring instruments and measuring reagents.

図1は疑似便を市販採便器の一つを使用して、疑似便を採取する工程を図示したものである。Aは採便器の中に装備している採便棒である。Bは希釈液を保持している希釈容器である。Cは採便棒を希釈容器の入り口に差し込む際に、入り口によって擦り取られた疑似便を示している。Dはヘモグロビンなどの分析装置の検体採取ノズルである。1は採便器の採便棒を外した状態である。2は採便棒を使って疑似便を採取した様子である。3は希釈容器の入り口から希釈容器の内部に採便棒を差し入れた様子であり、入り口の狭さが疑似便を擦りきって、一応一定量の疑似便が希釈液中に分散溶解する様子を示している。擦りきられて残った疑似便は容器の外側に残っている。4は疑似便が希釈容器の中の希釈液に溶解した様子を示している。5は容器を逆さまにして背後から分析装置の検体採取のノズルが注入された様子を示している。FIG. 1 illustrates a process of collecting simulated stool using one of commercially available stool collectors. A is a stool collection rod equipped in the stool collection device. B is a dilution container holding a diluent. C shows the artificial stool scraped by the entrance when the stool collection rod is inserted into the entrance of the dilution container. D is a sample collection nozzle of an analyzer such as hemoglobin. 1 is the state which removed the stool collection rod of the toilet stool. 2 shows a state in which simulated stool is collected using a stool collection stick. 3 shows a state in which a stool collection rod is inserted from the entrance of the dilution container into the inside of the dilution container. The narrowness of the entrance rubs the stool, and a certain amount of stool is dispersed and dissolved in the diluent. Show. The fake stool that remains after rubbing remains on the outside of the container. 4 shows a state in which the artificial stool is dissolved in the diluent in the dilution container. 5 shows a state where the sample collection nozzle of the analyzer is injected from behind with the container upside down.

添加するゼラチンやコラーゲンとしては、主として動物の組織由来のものが好適であるが、その分解物も使用できる。例示すれば、牛骨、牛皮、豚骨、豚皮、魚鱗、魚皮などから作られるもので、市販の食用のゼラチンでもよい。その他、これらを酵素などで低分子に分解したものも好適に使用できる。これらを含有させる濃度としては、0.01g/L〜50g/Lで効果は見られるが、好適には0.1〜10g/Lが良く、溶解させた溶液の粘度やゲルになる温度を鑑みて使用するのがよい。また一般的には分解されて低分子になったコラーゲンほど良く水に溶解する。 As gelatin and collagen to be added, those mainly derived from animal tissues are suitable, but degradation products thereof can also be used. For example, it is made from cow bone, cow skin, pig bone, pig skin, fish scale, fish skin, etc., and commercially available edible gelatin may be used. In addition, those obtained by decomposing them into low molecules with an enzyme or the like can also be suitably used. As the concentration to contain these, an effect is seen at 0.01 g / L to 50 g / L, but preferably 0.1 to 10 g / L, and in view of the viscosity of the dissolved solution and the temperature at which the gel is formed. It is good to use. In general, collagen that has been decomposed into low molecules dissolves better in water.

従来の擬似便を作成する方法としては、米粉など粉体の擬似便素材にヘモグロビンまたはトランスフェリンを溶解した溶液を添加して便の物理的な性状にする方法が行われるが、本発明では添加するヘモグロビンまたはトランスフェリンを溶解した溶液にゼラチンなどを添加していったん溶液とし、それを粉体素材と混ぜる場合と、米粉等の粉体にゼラチンやコラーゲンを溶解した液を添加・混合して均質化し、その後濾過して粉体を分離し、さらに乾燥させる処理を施して粉体をあらかじめ前処理し、最終的にヘモグロビンまたはトランスフェリンを溶解した溶液と混合する場合とがあり、どちらでも可能である。また、(特願2012―185962)に示された検出可能なグリセロールなどの第3の物質を添加した溶液に、本発明のゼラチンやコラーゲンまたはその分解物を添加して擬似便を作成することも可能である。また、ヘモグロビンまたはトランスフェリンを安定化させる物質として添加する糖類やアジ化ナトリウム、EDTA―Fe、SH基を持つようなN−アセチルシステインなども添加することも良い。
As a conventional method for producing artificial stool, a method of adding hemoglobin or transferrin solution to powdered artificial stool material such as rice flour to obtain physical properties of stool is performed, but in the present invention, it is added. Add gelatin etc. to a solution in which hemoglobin or transferrin is dissolved to make a solution once and mix it with the powder material, and add and mix a solution in which gelatin or collagen is dissolved in a powder such as rice flour, homogenize, Thereafter, the powder is separated by filtration, and further dried. The powder is pretreated in advance, and finally mixed with a solution in which hemoglobin or transferrin is dissolved, either of which is possible. Further, the artificial stool may be prepared by adding the gelatin or collagen of the present invention or a degradation product thereof to a solution in which a third substance such as detectable glycerol shown in (Japanese Patent Application No. 2012-185962) is added. Is possible. In addition, saccharide added as a substance that stabilizes hemoglobin or transferrin, sodium azide, EDTA-Fe, N-acetylcysteine having an SH group, or the like may be added.

50mMのMOPS緩衝液(pH7.5)100mLに牛皮由来ゼラチン(和光純薬製)500mg、スクロース500mg、アジ化ナトリウム100mgを溶解して、処理液を作成した。次に市販上用粉(豆平(株)製)30gに上記処理液90mLを添加していったんスパーテルで撹拌して均一にし、室温1時間放置後グラスフィルターにて濾過し、そのまま真空乾燥機中で1昼夜減圧乾燥した。
一方対照として、牛皮由来ゼラチンの代わりに牛血清アルブミン500mg、と牛皮由来ゼラチンなし、の2種類の対照処理液を作成し、上記と同様に処理して合計3種類の処理済み上用粉を作成した。
A treatment solution was prepared by dissolving 500 mg of cowhide-derived gelatin (manufactured by Wako Pure Chemical Industries, Ltd.), 500 mg of sucrose, and 100 mg of sodium azide in 100 mL of 50 mM MOPS buffer (pH 7.5). Next, 90 mL of the above processing solution was added to 30 g of commercially available flour (made by Tohirada Co., Ltd.), once stirred and homogenized with a spatula, allowed to stand at room temperature for 1 hour, filtered through a glass filter, and directly in a vacuum dryer. And dried under reduced pressure for 1 day.
On the other hand, instead of cowhide-derived gelatin, two types of control treatment solutions of bovine serum albumin 500 mg and cowhide-derived gelatin were prepared and processed in the same manner as above to produce a total of three types of processed top powder. did.

5g/Lの塩化ナトリウムを含む10mMリン酸緩衝液(pH7.5)に人ヘモグロビンA0(シグマアルドリッチ社製)を0.2mg/mLとなるように溶解した溶液(溶液Aとする。)を準備した。試験管に実施例1の3種類の処理済み上用粉それぞれを1gずつを取り、これに溶液Aを1.1mLずつ添加した。スパーテルで均一になるよう良く撹拌したところ、ペースト状の3種類の擬似便が作成された。擬似便1:無添加、擬似便2:牛皮由来ゼラチン添加、擬似便3:牛血清アルブミン添加とする。
5℃1時間放置後、それぞれの試験管に2mLの精製水を添加・撹拌した後、時々試験管ミキサーで撹拌しながらさらに1時間5℃で放置し、最後に遠心分離器で3000rpm、5分間遠心して上清を得た。
上清中のヘモグロビン濃度は以下の測定試薬および手順にて測定した。
ヘモグロビンの測定試薬組成は表1の通りである。

Figure 2014048074
A solution (referred to as Solution A) in which human hemoglobin A0 (manufactured by Sigma-Aldrich) was dissolved at 0.2 mg / mL in 10 mM phosphate buffer (pH 7.5) containing 5 g / L sodium chloride was prepared. did. In each test tube, 1 g of each of the three types of treated top powder of Example 1 was taken, and 1.1 mL of Solution A was added thereto. When stirred well with a spatula, three types of paste-like stool were prepared. Simulated stool 1: No addition, Simulated stool 2: Cow skin derived gelatin added, Simulated stool 3: Bovine serum albumin added.
After standing at 5 ° C. for 1 hour, 2 mL of purified water was added to each test tube and stirred, then left at 5 ° C. for an additional hour with occasional stirring with a test tube mixer, and finally at 3000 rpm for 5 minutes in a centrifuge. The supernatant was obtained by centrifugation.
The hemoglobin concentration in the supernatant was measured by the following measuring reagent and procedure.
The measurement reagent composition of hemoglobin is as shown in Table 1.
Figure 2014048074

ヘモグロビンの測定手順は、上記上清50μLに測定試薬3mLを添加して撹拌し、37℃15分間加温した後、666nmの吸光度を測定した。ヘモグロビン濃度の計算は、別途ヘモグロビンの標準液として実施例1の人ヘモグロビンA0を100μg/mLに溶解したものを用意し、同様に測定操作を行って比較した。なお、計算式にあるBは1.1mL、上用粉のDは別途測定し、0.43mLであり、A測定値は溶液Aを3倍希釈して測定後、結果を3倍した。
回収率は数式1によって計算し、結果を表2に示す。
擬似便に添加するものが、従来のアルブミンや、無添加の場合より良好な結果が得られた。

Figure 2014048074
The hemoglobin measurement procedure was performed by adding 3 mL of the measurement reagent to 50 μL of the supernatant and stirring, followed by heating at 37 ° C. for 15 minutes, and then measuring the absorbance at 666 nm. For the calculation of the hemoglobin concentration, a solution prepared by dissolving human hemoglobin A0 of Example 1 in 100 μg / mL as a standard solution of hemoglobin was prepared and compared in the same manner. In addition, B in the calculation formula was 1.1 mL, D of the upper powder was separately measured and was 0.43 mL, and the A measurement value was measured by diluting solution A three times, and the result was tripled.
The recovery rate was calculated by Equation 1 and the results are shown in Table 2.
What was added to the artificial stool gave better results than conventional albumin or no additive.
Figure 2014048074

実施例2の溶液Aの一部に牛骨由来のゼラチン(和光純薬製)を5mg/mLになるように添加してA´溶液を作成した。2本の試験管に無処理の上用粉1gを取り、これにAおよびA´溶液をそれぞれ1.1mLずつ添加した。スパーテルで均一になるよう良く撹拌して2種類の擬似便を作成した。
5℃1時間放置後、それぞれの試験管に2mLの精製水を添加・撹拌した後、時々試験管ミキサーで撹拌しながらさらに1時間5℃で放置し、最後に遠心分離器で3000rpm、5分間遠心して上清を得た。実施例2と同様に操作して、それぞれの回収率を計算した。結果を表2に示す。
なお、実施例3の場合の計算式1に相当するBは1.1mL、Dは別途測定し、0.43mL、A測定値は溶液AおよびA´液を3倍希釈して測定後、結果を3倍した。
実施例2の場合とほぼ同じように、ヘモグロビンを含有する溶液に直接ゼラチンを使用した場合においても98%以上の回収率が得られた。また一方ゼラチンを使用しない場合には90%前後の回収率であった。

Figure 2014048074
A part of the solution A of Example 2 was prepared by adding gelatin derived from bovine bone (manufactured by Wako Pure Chemical Industries, Ltd.) so as to be 5 mg / mL. 1 g of untreated top powder was taken in two test tubes, and 1.1 mL each of the A and A ′ solutions was added thereto. Two types of artificial stool were prepared by stirring well with a spatula to make it uniform.
After standing at 5 ° C. for 1 hour, 2 mL of purified water was added to each test tube and stirred, then left at 5 ° C. for an additional hour with occasional stirring with a test tube mixer, and finally at 3000 rpm for 5 minutes in a centrifuge. The supernatant was obtained by centrifugation. By operating in the same manner as in Example 2, each recovery rate was calculated. The results are shown in Table 2.
In addition, B corresponding to the calculation formula 1 in the case of Example 3 is 1.1 mL, D is separately measured, 0.43 mL, and A measurement values are obtained by diluting the solutions A and A ′ solutions three times, and the result. Was tripled.
As in the case of Example 2, a recovery rate of 98% or more was obtained when gelatin was directly used in a solution containing hemoglobin. On the other hand, when gelatin was not used, the recovery rate was about 90%.
Figure 2014048074

実施例2のゼラチンの代わりに、ゼラチンの分解物であるニッピコラーゲン100(ニッピコラーゲン化粧品(株)製)を使用して、実施例2と同様に実験したところ、ほぼ同様な結果を得た。
An experiment similar to that in Example 2 was performed using Nippi Collagen 100 (manufactured by Nippi Collagen Cosmetics Co., Ltd.), which is a degradation product of gelatin, instead of the gelatin of Example 2, and almost the same results were obtained.

実施例2の溶液Aにグリセロール(和光純薬(株)製)を10%添加したものを溶液Aの代わりに使用して、実施例3と同様に実験したところ、ほぼ同様な結果を得た。また、この擬似便は、一部採取した擬似便の量をグリセロール濃度の測定によって推量可能であった。
When a solution obtained by adding 10% glycerol (manufactured by Wako Pure Chemical Industries, Ltd.) to the solution A of Example 2 was used in place of the solution A, an experiment was performed in the same manner as in Example 3, and almost the same result was obtained. . In addition, the amount of artificial stool collected from this simulated stool could be estimated by measuring the glycerol concentration.

本発明によって、疑似便素材内部へのヘモグロビンやトランスフェリンが補足されない状況が完成するために、どの会社の採便システムを持ってきても理論通りの添加ヘモグロビンおよびトランスフェリンが回収される様になり、便中ヘモグロビンおよびトランスフェリン項目の全国的なサーベイが出来るようになり、標準化も可能になる。
Since the present invention completes the situation in which hemoglobin and transferrin are not supplemented inside the artificial fecal material, the added hemoglobin and transferrin as expected can be recovered regardless of the company's stool collection system. A nationwide survey of medium hemoglobin and transferrin items will be possible and standardization will be possible.

図1に用いられている符号は次の通りである。
A 採便棒
B 希釈容器
C 擦りきられ、口に残った疑似便
D ヘモグロビン測定器の検体ノズル
1は採便器の採便棒を外した状態。
2は採便棒を使って疑似便を採取した様子。
3は希釈容器の入り口から希釈容器の内部に採便棒を差し入れた様子。
4は疑似便が希釈容器の中の希釈液に溶解した様子。
5は容器を逆さまにして背後から分析装置の検体採取のノズルが注入された様子。




The symbols used in FIG. 1 are as follows.
A A stool collection rod B Dilution container C A fake stool that has been scraped off and remains in the mouth D The specimen nozzle 1 of the hemoglobin measuring device is in a state in which the stool collection rod is removed.
2 shows a sample of artificial stool collected using a stool collection stick.
3 shows a stool collection rod inserted into the dilution container from the entrance of the dilution container.
4 shows the simulated stool dissolved in the diluent in the dilution container.
5 shows that the sample collection nozzle of the analyzer was injected from behind with the container upside down.




Claims (6)

粉体に水溶液を浸潤させて作成するヘモグロビンまたはトランスフェリンを測定項目とする擬似便において、ゼラチン、コラーゲン、コラーゲンの分解物から選ばれる1つ以上を含有する事を特徴とする擬似便。 A pseudo stool characterized by containing at least one selected from gelatin, collagen, and a degradation product of collagen, which is hemoglobin or transferrin prepared by infiltrating a powder with an aqueous solution. 粉体に水溶液を浸潤させて作成するヘモグロビン及び・またはトランスフェリン測定用擬似便を製造する際に、ゼラチン、コラーゲン、コラーゲンの分解物から選ばれる1つ以上を添加する事を特徴とする擬似便の製造法。 A simulated stool characterized by adding one or more selected from gelatin, collagen, and a degradation product of collagen when producing hemoglobin and / or simulated stool for measurement of transferrin prepared by infiltrating a powder with an aqueous solution Manufacturing method. 請求項1のゼラチン、コラーゲン、コラーゲンの分解物が動物組織由来のゼラチン、コラーゲン、コラーゲンの分解物である擬似便。 The artificial stool in which the degradation product of gelatin, collagen or collagen of claim 1 is a degradation product of gelatin, collagen or collagen derived from animal tissue. 請求項1および請求項3の擬似便を使用して、便中ヘモグロビンまたはトランスフェリン項目の精度管理を行う方法。 A method for performing quality control of fecal hemoglobin or transferrin items using the artificial stool of claim 1 and claim 3. 請求項3の動物由来のゼラチン、コラーゲン、コラーゲンの分解物が、牛骨または牛皮、豚骨、豚皮、魚鱗、魚骨由来である請求項3の擬似便。 The artificial stool according to claim 3, wherein the animal-derived gelatin, collagen, or collagen degradation product of claim 3 is derived from cow bone or cow skin, pig bone, pig skin, fish scale, or fish bone. 請求項5の疑似便を使用して、便中ヘモグロビンまたはトランスフェリン項目の精度管理を行う方法。

A method for performing quality control of fecal hemoglobin or transferrin items using the artificial stool of claim 5.

JP2012189325A 2012-08-29 2012-08-29 Artificial stool composition having good addition recovery ratio Pending JP2014048074A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012189325A JP2014048074A (en) 2012-08-29 2012-08-29 Artificial stool composition having good addition recovery ratio

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2012189325A JP2014048074A (en) 2012-08-29 2012-08-29 Artificial stool composition having good addition recovery ratio

Publications (1)

Publication Number Publication Date
JP2014048074A true JP2014048074A (en) 2014-03-17

Family

ID=50607920

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012189325A Pending JP2014048074A (en) 2012-08-29 2012-08-29 Artificial stool composition having good addition recovery ratio

Country Status (1)

Country Link
JP (1) JP2014048074A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020059563A1 (en) * 2018-09-19 2020-03-26 栄研化学株式会社 Artificial feces, and method for managing accuracy of fecal occult blood test using same

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020059563A1 (en) * 2018-09-19 2020-03-26 栄研化学株式会社 Artificial feces, and method for managing accuracy of fecal occult blood test using same
JP2020052038A (en) * 2018-09-19 2020-04-02 栄研化学株式会社 Simulated stool and accuracy control method for fecal occult blood test using the same
JPWO2020059563A1 (en) * 2018-09-19 2021-08-30 栄研化学株式会社 Simulated stool and quality control method for fecal occult blood test using this
JP7348908B2 (en) 2018-09-19 2023-09-21 栄研化学株式会社 Simulated stool and accuracy control method for fecal occult blood testing using it
JP7348780B2 (en) 2018-09-19 2023-09-21 栄研化学株式会社 Simulated stool and accuracy control method for fecal occult blood testing using it

Similar Documents

Publication Publication Date Title
Gil et al. Toxicological importance of human biomonitoring of metallic and metalloid elements in different biological samples
Kim et al. Methods to collect, preserve, and prepare elasmobranch tissues for stable isotope analysis
Joseph et al. The effects of glycation on the binding of human serum albumin to warfarin and L-tryptophan
CN105352958B (en) Total 25-hydroxy-vitamin D detection kit
CN102226805B (en) Middle/low concentration positive quality control liquid for urine analysis
Gelman et al. Collagen fibril formation in vitro. A quasielastic light-scattering study of early stages.
CN109239065A (en) A kind of stable urine total protein quality-control product and its preparation method and application
CN106645665A (en) Thrombin time detection reagent
Gümüş et al. Evaluation of the postmortem glucose and glycogen levels in hepatic, renal, muscle, and brain tissues: is it possible to estimate postmortem interval using these parameters?
CN104596824A (en) Chicken matrix reference material containing amantadine and ribavirin and preparation method of chicken matrix reference material
CN104166004B (en) Blood coagulation factor Ⅷ quality control product preparation method
JP7348780B2 (en) Simulated stool and accuracy control method for fecal occult blood testing using it
JP2014048074A (en) Artificial stool composition having good addition recovery ratio
Kechik et al. Establishment of the collection, storage and preservation methods and their influence on stability of human salivary exosome
CN106908612B (en) A kind of albumin detection reagent box that antiheparin is stable
Nermo et al. Trend analyses of persistent organic pollutants in human milk from first-time mothers in Norway between 2002 and 2021
CN104391124B (en) A kind of myoglobins detects the preparation method of reagent
CN103237899A (en) Bioassay method of Dajianzhongtang and quality control method using the method
Guimarães et al. Lead concentration in feces and urine of exposed rats by x‐ray fluorescence and electrothermal atomic absorption spectrometry
US6933152B1 (en) Artificial human feces
CN113419015A (en) Preparation method and application of natural tetrodotoxin standard sample based on puffer fish base material
Rusin et al. Development of the CE-C4D method for determination of organic acids in infants faeces using an in-house built instrument
JP5963984B2 (en) Sample pretreatment method for thyroid stimulating antibody measurement
JP5957641B2 (en) Simulated stool composition
CN104730236A (en) Protein fixing reagent and application thereof